Introduction to Biologics and Biosimilars Law and Regulation Course

Explore the regulation of biological products, including biotechnology–derived therapeutic proteins, human tissue, gene, and cell products. Learn about the abbreviated pathway to market for biosimilar biological products and associated intellectual property issues, including exclusivity and biologics patent litigation. Case studies, hypotheticals, and ample time for Q&A is provided. Elaine Herrmann Blais is speaking at the Introduction to Biologics and Biosimilars Law and Regulation course through the Food and Drug Law Institute.